Monday broker round-up UPDATE

Anglo American: Exane reduces target price from 1700p to 1400p and reiterates its underperform rating.Anite Group: Investec raises target price from 135p to 155p and upgrades from hold to buy.Ashmore Group: RBC Capital Markets takes target price from 440p to 375p and keeps its neutral rating.Balfour Beatty: Bank of America cuts target price from 255p to 240p and downgrades to neutral.Bovis Homes Group: Jefferies ups target price from 897p to 909p keeping a buy recommendation. Panmure Gordon raises target price from 660p to 714p and retains a hold recommendation.Escher Group: Panmure Gordon moves target price from 459p to 465p reiterating a buy recommendation.Fidessa: Sanlam Securities increases target price from 2000p to 2340p and stays with a buy recommendation.Hikma Pharmaceuticals: HSBC Holdings raises target price from 745p to 1035p, while retaining a neutral rating. Panmure Gordon takes target price from 1000p to 1100p and leaves its buy recommendation unaltered.Interserve: Westhouse Securities ups target price from 537p to 582p keeping an add rating.Investec: Morgan Stanley lowers target price from 525p to 500p and maintains an overweight rating.Petropavlovsk: Goldman Sachs revises target price from 106p to 76p and keeps its sell recommendation.Polymetal International: HSBC Holdings reduces target price from 1000p to 620p, while leaving its overweight rating unchanged. Goldman Sachs cuts target price from 800p to 340p downgrading from neutral to sell.Polyus Gold International: Goldman Sachs moves target price from 230p to 210p leaving its neutral rating unaltered.Restaurant Group: JP Morgan increases target price from 525p to 565p and reiterates an overweight rating.Spirent Communications: Goldman Sachs shifts target price from 164p to 160p, but leaves its buy recommendation unchanged.Synergy Health: Investec downgrades from buy to add with a target price of 1170p.Vodafone: Credit Suisse moves target price from 180p to 195p and retains an outperform rating.Young & Co's Brewery: JP Morgan takes target price from 840p to 910p and stays with its overweight rating. Balfour Beatty Investec Hikma Pharmaceuticals Vodafone Ashmore Group Young & Co's Brewery Ashoka India Equity Investment Trust Plc Atlantic Lithium